Evidence map›Paper›PMID 39790369›Full record

ArticleJTO clinical and research reports2025

State of Lung Cancer in Egypt: Moving Towards Improved Guidelines for Prevention, Screening, Treatment, and Clinical Care Programs.

Nagla Abdel Karim, Ahmed Magdy Rabea, Philip C Mack, Janakiraman Subramanian, Ehab Khalil, Mai Sherif, Radwa Marawan, Tagrid Gaafar, Lobna Shash, Kei Suzuki and 22 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in JTO clinical and research reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

32 authors.

Nagla Abdel KarimInova Schar Cancer Institute, Virginia, USA.
Ahmed Magdy RabeaNational Cancer Institute, Cairo University, Cairo, Egypt.
Philip C MackIcahn School of Medicine at Mount Sinai, New York, New York.
Janakiraman SubramanianInova Schar Cancer Institute, Virginia, USA.
Ehab KhalilNational Cancer Institute, Cairo University, Cairo, Egypt.
Mai SherifKasr Al Aini Faculty of Medicine-Cairo University, Cairo, Egypt.
Radwa MarawanKasr Al Aini Faculty of Medicine-Cairo University, Cairo, Egypt.
Tagrid GaafarKasr Al Aini Faculty of Medicine-Cairo University, Cairo, Egypt.
Lobna ShashFaculty of Medicine-Ain Shams University, Cairo, Egypt.
Kei SuzukiInova Schar Cancer Institute, Virginia, USA.
Manmeet AhluwaliaMiami Cancer Institute, Miami, Florida.
Hisham WahbaNational Cancer Institute, Cairo University, Cairo, Egypt.
Salma AboelelaNational Cancer Institute, Cairo University, Cairo, Egypt.
Asrar Al AhmadiOhio State University, Ohio, USA.
Hamed Al HusainiKing Faisal Specialist Hospital, Cairo, Egypt.
Nada MohsenNational Cancer Institute, Cairo University, Cairo, Egypt.
Rana KhaledNational Cancer Institute, Cairo University, Cairo, Egypt.
Neemat KassemKasr Al Aini Faculty of Medicine-Cairo University, Cairo, Egypt.
Hussein KhaledNational Cancer Institute, Cairo University, Cairo, Egypt.
Noha El SaidNational Cancer Institute, Cairo University, Cairo, Egypt.
Nadia ZakharyNational Cancer Institute, Cairo University, Cairo, Egypt.
Dina ShoukryKasr Al Aini Faculty of Medicine-Cairo University, Cairo, Egypt.
Alaa Abdullah ElSadiequeEgyptian Cancer Research Network, Academy of Scientific Research and Technology, Cairo, Egypt.
M Yasser AlsedfyEgyptian Cancer Research Network, Academy of Scientific Research and Technology, Cairo, Egypt.
Shaheen IslamDepartment of Pulmonary, Augusta University, Augusta, Georgia, USA.
Hend ElSherbinyKasr Al Aini Faculty of Medicine-Cairo University, Cairo, Egypt.
Mervat El DeftarNational Cancer Institute, Cairo University, Cairo, Egypt.
Noha AwadEgyptian Cancer Research Network, Academy of Scientific Research and Technology, Cairo, Egypt.
Abdel Rahman MohamedNational Cancer Institute, Cairo University, Cairo, Egypt.
David GandaraUC Davis Cancer Center, USA.
Karen KellyUC Davis Cancer Center, USA.
Triparna SenIcahn School of Medicine at Mount Sinai, New York, New York.

Funding

Wellcome Trust
6 · The paper itself

Abstract

Lung cancer remains a leading cause of cancer-related mortality globally and presents significant challenges in Egypt. In 2023, the first annual meeting of the Thoracic Oncology Multidisciplinary Faculty, organized by the Egyptian Cancer Research Network and the Egyptian Society of Respiratory Neoplasms, was held in Cairo, Egypt. The meeting aimed to address gaps in lung cancer management across Egypt and the broader Middle East and North Africa region. The discussions focused on the challenges posed by NSCLC and SCLC and emphasized the need for enhanced prevention, early detection, and treatment strategies. Key areas of concern include limited access to advanced diagnostics, such as comprehensive genomic profiling, and the underutilization of targeted therapies and immunotherapies, mainly owing to financial barriers. The meeting highlighted the importance of strengthening lung cancer screening programs, improving smoking cessation efforts, and addressing environmental risk factors like air pollution. Furthermore, the event underscored the need for greater research and collaboration, particularly in areas like precision oncology. The conference concluded with strategic recommendations to improve lung cancer prevention, screening, and treatment, aligning Egypt's lung cancer care with global advancements and ensuring equitable access to cutting-edge therapies.

Indexed as

Air pollutionGlobal healthLung cancerMENA regionSmoking cessation

Identifiers

PMID39790369
PMCPMC11712008

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.